Abstract
Mild Cognitive Impairment (CCL) and Subjective Cognitive Decline (DCS) are considered possible preclinical indicators of Alzheimer's Disease (AD). Thus, the risks of increased conversion rate (10 to 15% per year) for prevalence are higher in patients with these conditions. Given this, increase the need for studies that previously alter consultations, to aid in early diagnosis and thus inc…